Skip to content

Auriculotherapy effectiveness for the reduction of musculoskeletal pain, anxiety and stress in healthcare workers

Auriculotherapy effectiveness in reducing health problems among hospital workers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3jvmdn
Enrollment
Unknown
Registered
2020-07-30
Start date
2021-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal pain

Interventions

Participants will have the application of auriculotherapy with mustard seeds and semi permanent needles. In subproject 1, mustard seeds will be used, after initial screening, in which the level of mus
semi-permanent needles will remain for 3 days. Participants will be instructed on care: daily manual stimulation of the seeds, at least three times a day, 15 times, at each auricular point. Participan
E02.190.204

Sponsors

Tânia Solange Bosi de Souza Magnago
Lead Sponsor
Universidade Federal de Santa Maria
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Subproject 1: present availability for auriculotherapy sessions; and, having chronic pain in the spine region (cervicalgia, chest pain and/or low back pain) lasting at least 3 months; and with a minimum intensity of 4 on the Numerical Pain Scale. Subproject 2: Nursing professionals, working in the General Surgery Unit – Inpatient Service, in the Operating Room, in the Anesthetic Recovery Room and in the Intermediate Recovery Room; professionals who are working during the data collection period, and who are available to carry out the auriculotherapy sessions. Being anxious (values = 10 are considered positive for the occurrence of anxiety disorder according to the GAD-7 Generalized Anxiety Disorder instrument) and having a medium level of stress (29 to 60 points) according to the List of Signs and Symptoms of Stress

Exclusion criteria

Exclusion criteria: Subproject 1: Being pregnant; present allergy to seeds; having inflammation in the atrium; be undergoing treatment for chronic musculoskeletal pain with alternative therapies and patients diagnosed with renal lithiasis with surgical indication. Subproject 2: Being pregnant; Using psychotropic medication or other therapy for the treatment of mental disorders during the study period

Design outcomes

Primary

MeasureTime frame
Reduction of anxiety; measurement will occur through GAD-7-General Anxiety Disorder; the measurement will occur in four moments: 1st session, 4th session, 8th session and 15 days after the last;Stress level reduction; measurement will occur through the Stress Signs and Symptoms List (LSS); the measurement will occur in four moments: 1st session, 4th session, 8th session and 15 days after the last one;Reduction in the intensity of musculoskeletal pain; measurement will occur through the Numerical Pain Scale and Brief Pain Inventory; the measurement will occur in four moments: 1st session, 4th session, 8th session and 15 days after the last one

Secondary

MeasureTime frame
Reduction in the prevalence of burnout; measurement will occur through the Maslach Burnout Inventory; the measurement will occur in four moments: 1st session, 4th session, 8th session and 15 days after the last one;Reduction of physical disability; measurement using the Brazilian version of the Roland-Morris Disability Questionnaire; measurement will take place in four moments: 1st session, 4th session, 8th session and 15 days after the last;Improved quality of life; Measurement through SF-36; measurement will take place in four moments: 1st session, 4th session, 8th session and 15 days after the last

Countries

Brazil

Contacts

Public ContactTânia Magnago

Universidade Federal de Santa Maria

magnago.tania@gmail.com+55-055-32208263

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 9, 2026